Healthium Medtech IPO – Review, Bid, Size, Allotment, Subscription, GMP & RHP
Last Updated Date: Nov 17, 2022Let’s have a detailed review of the company and analytics of the Healthium Medtech IPO release date, IPO offer price, subscription, Healthium Medtech Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.
| Face Value | Rs 1 |
| Price Band | Rs [●] |
| Listing At | BSE, NSE |
| Min. Order Quantity | NA |
| Listing Date | NA |
| Offer for Sale | Rs Million |
| Fresh Issue | Rs 3,900.00 Million |
| IPO Size | Rs Million |
| Tick Size | 1 |
Healthium Medtech IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.
Healthium Medtech IPO – Summary
They are a global MedTech company focused on products used in surgical, post-surgical, and chronic care.
Their vision is to deliver access to precision medtech products to every patient globally.
They operate across three key markets, namely, India, the UK, and the rest of the world, and four focus areas, namely, advanced surgery, urology, arthroscopy, and wound care.
One in five surgeries conducted globally uses a Healthium product as of March 31, 2021. The Promoter of this company is QUINAG ACQUISITION (FDI) LIMITED.
The lead manager to the issue is ICICI Securities Limited, CLSA India Private Limited, Credit Suisse Securities (India) Private Limited, and Nomura Financial Advisory and Securities (India) Private Limited, and the Registrar to this issue is KFin Technologies Private Limited.
Healthium Medtech IPO Date
The opening and the closing date of Healthium Medtech IPO are not available yet.
Check out Related IPO Links:
| Healthium Medtech IPO GMP |
| Allotment – Healthium Medtech IPO |
Healthium Medtech IPO Subscription
| Day / Date | QIB | NII | RII | Total Subscription |
| 1st Day – | ||||
| 2nd Day – | ||||
| 3rd Day – | ||||
| Shares Offered or Net Issue |
The shares subscribed by the public will be updated here.
Check Healthium Medtech IPO LIVE Subscription
- Healthium Medtech IPO LIVE Bid details on BSE
- Healthium Medtech IPO LIVE Bid details on NSE
For the Latest Bid details click on the above links.
Healthium Medtech IPO Allotment Status
Here, you can find the Allotment Status of this IPO.
Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders.
However, the Allotment Status is not yet disclosed.
Healthium Medtech Limited IPO Listing Date
Find the dates below on basis of allotment, refund, listing, and more:
| Basis of Allotment Finalization | – |
| Refunds Initiation | – |
| Credit of Shares to Demat Account | – |
| Share Listing Date | – |
Healthium Medtech IPO Price Band
The face value of each share is Rs.1, but the price band of the IPO is Rs.[●]
Healthium Medtech IPO Equity Size
This Initial Public Issue of X Equity Shares of Rs.1 each for cash at a price of Rs.[●] per equity share aggregating to Rs.[●] Million.
Healthium Medtech IPO Share Offering
Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of [●] Equity Shares of Rs.1/ each.
Issue Size: X Equity Shares of Rs.1 each, aggregating to Rs.[●] Million
Open Free Demat Account Now!
Healthium Medtech IPO – Live Performance
The listing date of this IPO is [●]. You can check the live performance of the IPO here, only after it is listed on exchanges.
| Live IPO Performance – Healthium Medtech Share Price |
Healthium Medtech IPO Grey Market Premium
The Healthium Medtech Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is X.
Healthium Medtech IPO – Company Overview
They are the largest independent medical device company and the second-largest company overall, in the surgical consumables market in India with a 7.91% share based on value; the largest non-captive surgical needles manufacturer, with a 22.30% share in overall volume sales globally, and 45.41% share of the non-captive market; and one of the largest independent medical device companies and the third-largest company overall in the urology collection devices market in the UK, with a 13.96% market share.
They have gained market share across their markets and focus areas between Fiscals 2019 and 2021 while improving profitability over this period.
Healthium Medtech competes primarily against large multinational corporations and various local players in each of their key markets and focus areas.
They offer a comprehensive portfolio of quality products at compelling value and they believe this differentiates them from their competitors.
Their quality and value proposition aligns them with the focus of healthcare stakeholders such as governments, hospitals, payers, and surgeons on improving the affordability of, and access to, quality healthcare.
Further, they believe that their well-established corporate and product brands and relationships with hospitals, surgeons, and distributors create competitive advantages for their business.
Healthium Medtech IPO – Financial Statements
A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:
Financial Summary:
| Amount (in INR & Million) | |||
| 31-Mar-21 | 31-Mar-20 | Mar-19 | |
| Total Assets | 7,917.77 | 7,103.08 | 6,833.42 |
| *Total Revenue | 7,267.58 | 6,523.81 | 5,889.04 |
| Total Expense | 5,889.04 | 5,783.49 | 5,251.10 |
| Profit After Tax | 854.28 | 367.60 | 137.31 |
Earnings per Equity Share (in Million)
| 31-Mar-21 | 31-Mar-20 | Mar-19 | |
| Basic & Diluted | 18.47 | 7.95 | 2.97 |
Further, their PAT for the period ended on March 31, 2021, March 31, 2020, and March 31, 2019, were Rs. 854.28 Million, Rs. 367.60 Million, and Rs. 137.31 Million respectively.
Healthium Medtech IPO – Promoters
The Promoter of this company is:
- QUINAG ACQUISITION (FDI) LIMITED
List of Related Parties (Key Managerial Personnel)
- Ajay Gupta, Chairman, and Non-Executive Independent Director
- Anish Bafna, Managing Director and Chief Executive Officer
- Mohammed Azeez, Whole-time Director, and Chief Operating Officer
- Ramesh Subrahmanian, Non-Executive Independent Director
- Shashank Singh, Non-Executive Nominee Director
- Steven Dyson, Non-Executive Nominee Director
Healthium Medtech IPO – Promoters Holding
- Pre Issue Share Holding – %
- Pos Issue Share Holding – %
Healthium Medtech IPO Offer Details or Issue Details
| Particulars | No. Of Equity Shares |
| Equity Shares Offered | Up to X Equity Shares aggregating up to Rs.[●] Million |
| of which: | |
| Issue Reserved for the Market Makers | Up to [●] Equity Shares aggregating up to Rs.[●] Million |
| Net Issue to the Public | Up to [●] Equity Shares aggregating up to Rs.[●] Million |
| Of which: | |
| Retail Investors Portion | Not less than [●] Equity Shares |
| Other than Retail Individual Investors | Not more than [●] Equity Shares |
| Equity Shares outstanding prior to the Issue | 97,761,124 Equity Shares |
| Equity Shares outstanding after the Issue | X Equity Shares |
Healthium Medtech IPO Issue Object
Their Company proposes to utilize the Net Proceeds towards funding the following objects:
I. Repayment and/or pre-payment, in full or part, of certain borrowings availed by their Company;
II. Investment into their Subsidiaries, Sironix Medical Technologies B.V. (“Sironix”), Clinisupplies Limited (“Clinisupplies”) and Quality Needles Private Limited (“Quality Needles”);
III.Acquisitions and other strategic initiatives; and
IV.General corporate purposes
Healthium Medtech IPO – Business Strategy
- Deepen and expand their geographical presence
- Expand their product portfolio
- Continue to grow their business inorganically through acquisitions to consolidate in fragmented markets
- Focus on continuous improvement of key operational metrics
Healthium Medtech IPO – Basis of Offer Price
The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.
Qualitative factors are:
- They are a leading medtech company with a global reach, and are well-positioned to benefit from favorable industry dynamics in high growth markets;
- They have an innovative and comprehensive product suite driven by their focused research and development efforts, and have a proven track record of commercializing their products;
- Have an extensive sales network and market access across their focus areas with long-standing relationships with their customers;
- They have high precision, integrated, and scaled manufacturing facilities with global certifications;
- They have a proven track record of driving inorganic growth and successfully integrating acquired businesses;
- Have a proven track record of robust financial performance; and
- They have an experienced and diverse senior management team supported by Quinag, their majority shareholder, ultimately owned by funds advised by Apax.
The relevant quantitative factors are:
| Basic & Diluted EPS | RONW (%) | NAV (Rs.) | |
| 31-Mar-21 | 9.23 | 8.70 | 105.84 |
| 31-Mar-20 | 3.98 | 1.43 | – |
| Mar-19 | 1.49 | 1.43 | – |
Healthium Medtech IPO: Competitive Peers
| Face Value (Rs.) | P/E | EPS (Rs.) | Return on Net Worth (%) | Total Income (Rs. in Millions) | |
| Healthium Medtech Limited | 10 | [●] | 9.23 | 8.70 | 7,267.58 |
| Listed Peers | |||||
| NA | – | – | – | – | – |
Healthium Medtech IPO Lead Managers
| Lead Managers |
| ICICI Securities Limited
CLSA India Private Limited Credit Suisse Securities (India) Private Limited Nomura Financial Advisory and Securities (India) Private Limited |
Healthium Medtech IPO Registrar to offer
| Registrar to the Offer |
| KFin Technologies Private Limited Selenium, Tower B, Plot No- 31 and 32, Financial District, Nanakramguda, Serilingampally, Hyderabad, Rangareedi 500 032, Telangana, India Tel: +91 40 6716 2222 E-mail: hml.ipo@kfintech.com Investor Grievance E-mail: einward.ris@kfintech.com Website: www.kfintech.com Contact Person: M Murali Krishna SEBI Registration No.: INR000000221 |
Healthium Medtech IPO – Other Details
- Statutory Auditor – S. R. Batliboi & Associates LLP
- Legal Counsel to the Company – Cyril Amarchand Mangaldas
- Bankers to the Company – The Hongkong and Shanghai Banking Corporation Limited, India
Healthium Medtech IPO Review by Stock Brokers
| Top Stock Brokers Review | Company Reputation | Competitive Edge | Financial Statement | Popularity Index | Promoters Reputation |
| Angel Broking | 7.5/10 | 7.4/10 | 8.5/10 | 8.1/10 | 7.1/10 |
| Sharekhan | 7.2/10 | 7.1/10 | 8.6/10 | 8.1/10 | 7.2/10 |
| Kotak Securities | 7.3/10 | 7.5/10 | 8.4/10 | 8.1/10 | 7.3/10 |
| ICICI Direct | 7.3/10 | 7.3/10 | 8.7/10 | 8.1/10 | 7.1/10 |
| IIFL | 7.5/10 | 7.2/10 | 8.8/10 | 8.0/10 | 7.1/10 |
| Edelweiss | 7.5/10 | 7.4/10 | 8.4/10 | 8.3/10 | 7.2/10 |
| Zerodha | 7.4/10 | 7.1/10 | 8.5/10 | 8.1/10 | 7.0/10 |
| 5Paisa | 7.1/10 | 7.1/10 | 8.4/10 | 8.1/10 | 7.1/10 |
| Karvy | 7.4/10 | 7.3/10 | 8.2/10 | 8.1/10 | 7.1/10 |
| Motilal Oswal | 7.1/10 | 7.1/10 | 8.6/10 | 8.3/10 | 7.2/10 |
Subscribe to Healthium Medtech IPO
Healthium Medtech Limited IPO News
News 1 – IPO DRHP Download
News 2 – IPO RHP Prospectus Download
Healthium Medtech IPO Review FAQs
Ques – What is the Issue Size of Healthium Medtech IPO?
Answer – The Company is making an initial public offer of NA equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.
Ques – What is the Price band of Healthium Medtech IPO?
Answer – The price band for this particular IPO ranges between NA. As far as the face value of the share is of concern, it is Rs.1 per share.
Ques – What is the Healthium IPO Open Date?
Answer – The opening and closing dates for this IPO have been updated. The IPO is set to open on NA, while the closing date is set at NA.
Ques – What is the Healthium IPO Allotment Date?
Answer – They also have the news regarding the respective allotment dates of this IPO. Basis of Allotment finalization is on NA, refund initiation is on NA, credit of shares is on NA, and share listing date is on NA.
Ques – What is the Healthium Medtech IPO Listing Date?
Answer – Shares of this company shall be listed in the exchanges NA. The date, when the listing would be done, is stagnant on NA.
Ques – Who is the Registrar of Healthium IPO?
Answer – One of the reputed registrars is managing the issue of this IPO, i.e. KFin Technologies Private Limited. Their website will help you regarding the further information you are on the lookout for.
Ques – Who is the Promoter of Healthium IPO?
Answer – Here are the promoters of this IPO – QUINAG ACQUISITION (FDI) LIMITED. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.
Ques – What is the GMP of Healthium IPO?
Answer – They have obtained the GMP of this IPO and it is NA. Further insights of Kostak rate and subject to sauda or SS are as well included in this report.
Ques – Is Healthium Medtech IPO good for Investment?
Answer – They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.
Ques – What is the PAT of Healthium Medtech?
Answer – They have the information of company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2021 in Million is 854.28, 2020 is 367.60, 2019 is 137.31.
Calculate your return on investment!
Asset Class
ROI (Rs.)
Profit (Rs.)
Profit (%)
IPO
Equity
Savings
Real Estate
Gold
Bonds
Fixed Deposit
Mutual Fund
Featured Topics